Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 507190856 series 2930024
Content provided by Luis Plaza. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Luis Plaza or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Bloodstream infections can progress rapidly to sepsis—bringing high costs, high mortality, and lasting effects. In the second episode of this series in collaboration with bioMérieux, Luis speaks with Dr. Jeff Cies, Senior Medical Advisor at bioMérieux, about how molecular diagnostics are reshaping bloodstream infection diagnosis.
They discuss:
Limitations of traditional blood cultures
How rapid molecular tests deliver results faster than ever
The impact on outcomes, costs, and antimicrobial resistance
The role of stewardship programs in maximizing results
What the future holds: direct-from-blood testing, nanotechnology, and AI
A powerful look at how innovation in microbiology is changing the fight against sepsis and saving lives.
This episode is sponsored by bioMérieux, a global innovator in infectious disease diagnostics.
Resources from this episode:
Stay connected with Let’s Talk Micro:
Website: letstalkmicro.com
Questions or feedback? Email me at [email protected]
Support the podcast:
215 episodes
))
